Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Antimicrobial use in animals ‘should be reduced’
pig vet
RUMA chair Gwyn Jones said it was positive that EMA and EFSA recognised there is no ‘one size fits all approach’.
EMA and EFSA advocate ‘reduce, replace, re-think’
 
EU agencies have said the use of antimicrobials in animals should be reduced and replaced where possible, and new farming systems introduced to prevent infectious diseases.

In a joint statement, the European Medicines Agency (EMA) and European Food Safety Authority (EFSA) said the use of antimicrobials in food-producing animals should be reduced to the minimum amount needed to treat infectious diseases.

Experts concluded that, apart from in exceptional cases, preventative use of antimicrobials should be phased out in favour of alternative measures, and antibiotics that are critically important for human medicine should only be used in animals as a last resort.

EFSA’s executive director Dr Bernhard Url commented: “It is clear that strategies that are already available can be implemented immediately and will have a positive impact on levels of antimicrobial resistance. At the same time, there is a need for innovative solutions – we need to find alternative ways to prevent and treat bacterial infections in animals.”

Alternatives to antimicrobials that have been shown to improve animal health include vaccines, probiotics, prebiotics, bacteriophages and organic acids.

However, EMA and EFSA stressed that reducing the use of antimicrobials and finding alternatives is not enough. Livestock systems need to be rethought, and farming practices implemented to prevent the introduction and spread of disease on farms.

The conclusions were welcomed by RUMA, which promotes responsible use of medicines in farming. RUMA chair Gwyn Jones said it was positive that EMA and EFSA recognised there is no ‘one size fits all approach’ and different situations require different approaches.

“There has been a tendency for critics to promote alternative farming systems or demand blanket implementation of rules in other countries, when that we actually need is to reduce use in a sustainable way that safeguards animal welfare.”

Mr Jones added that the UK is already well on the way to meeting its target to reduce antibiotic use by nearly a fifth by 2018. Poultry meat companies stopped prophylactic use of all antibiotics in 2016 by working with the British Poultry Council, although RUMA says it recognises that preventative treatment will be needed temporarily while the vet and farmer make improvements to biosecurity and husbandry.

Use of critically important antibiotics has also been voluntarily restricted by the poultry, pig and now cattle sectors.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.